Atlas Trials

Isoleucine Intake and Intermediary Metabolism in Type 2 Diabetes

Clinical trial NCT04461236 · COMPLETED

Trial details

NCT number
NCT04461236
Sponsor
Texas A&M University
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Type 2 Diabetes
Start date
2019-05-30
Primary completion
2020-03-02
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.